Lior Raviv | CTO
Pluri

Lior Raviv, CTO, Pluri

Appearances:



Day 2: 18th March 2026 @ 13:35

Panel Discussion: Manufacturing Strategies: Decentralised Vs. Centralised Approaches for Cell Therapies

Moderator: Kat Kozyrytska, Founder, Cell Therapy Manufacturability Program
Sandeep Kumar, Head of Advanced Therapy Production, Guy's and St Thomas' NHS Foundation Trust
Sarah Snykers, Head of Operations, Legend Biotech
Stephen Sullivan, Director, Lindville Bio
Urvi Thacker, Associate Director, MSAT, Quell Therapeutics
Valentin von Werz, Post Doc Reseracher, TU Wien
Lilian Hook, Director of Cell, Apheresis and Gene Therapies, NHS Blood and Transplant
Lior Raviv, CTO, Pluri

Day 2: 18th March 2026 @ 15:50

Leveraging technological innovation to support allogenic manufacturing

Lior Raviv, CTO, Pluri
last published: 16/Sep/25 09:55 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150